AAREYDRUGSPharmaceuticals
Aarey Drugs & Pharmaceuticals Ltd — Cash Flow Statement
₹50.75
-9.78%
Aarey Drugs & Pharmaceuticals Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Free Cash Flow | 4.45 Cr | -3.72 Cr | -2.33 Cr | -1.70 Cr | — |
| Repayment Of Debt | -1.51 Cr | -1.14 Cr | 0.00 | -3.98 Cr | — |
| Issuance Of Capital Stock | 1.70 Cr | 11.08 Cr | 0.00 | 8.23 Cr | — |
| Capital Expenditure | -5.20 Cr | -0.72 Cr | -1.04 Cr | -2.20 Cr | — |
| End Cash Position | 1.47 Cr | 1.59 Cr | 0.71 Cr | 0.19 Cr | — |
| Other Cash Adjustment Outside Changein Cash | 1000.00 | -1000.00 | — | -2.00 | -1.00 |
| Beginning Cash Position | 1.59 Cr | 0.71 Cr | 0.19 Cr | 0.65 Cr | — |
| Changes In Cash | -0.12 Cr | 0.89 Cr | 0.51 Cr | -0.46 Cr | — |
| Financing Cash Flow | -3.83 Cr | 5.58 Cr | 1.35 Cr | 2.25 Cr | — |
| Net Other Financing Charges | -0.01 Cr | -0.06 Cr | — | 1000.00 | — |
| Interest Paid Cff | -4.02 Cr | -4.38 Cr | -2.87 Cr | -2.00 Cr | — |
| Net Preferred Stock Issuance | 0.00 | 2.67 Cr | 0.00 | 8.23 Cr | — |
| Preferred Stock Issuance | 0.00 | 2.67 Cr | 0.00 | 8.23 Cr | — |
| Net Common Stock Issuance | 1.70 Cr | 8.41 Cr | 0.00 | 8.23 Cr | — |
| Common Stock Issuance | 1.70 Cr | 8.41 Cr | 0.00 | 8.23 Cr | — |
| Net Issuance Payments Of Debt | -1.51 Cr | -1.06 Cr | 4.22 Cr | -3.98 Cr | — |
| Net Long Term Debt Issuance | -1.51 Cr | -1.06 Cr | 4.22 Cr | -3.98 Cr | — |
| Long Term Debt Payments | -1.51 Cr | -1.14 Cr | 0.00 | -3.98 Cr | — |
| Investing Cash Flow | -5.94 Cr | -1.70 Cr | 0.44 Cr | -3.21 Cr | — |
| Net Investment Purchase And Sale | -0.73 Cr | -0.98 Cr | 1.49 Cr | -2.39 Cr | — |
| Sale Of Investment | 0.00 | 0.00 | 1.90 Cr | 0.00 | — |
| Purchase Of Investment | -0.73 Cr | -0.98 Cr | -0.42 Cr | -2.39 Cr | — |
| Net PPE Purchase And Sale | -5.20 Cr | -0.72 Cr | -1.04 Cr | -2.20 Cr | — |
| Sale Of PPE | 0.00 | 0.00 | 0.00 | 46000.00 | — |
| Purchase Of PPE | -5.20 Cr | -0.72 Cr | -1.04 Cr | -2.20 Cr | — |
| Operating Cash Flow | 9.65 Cr | -2.99 Cr | -1.28 Cr | 0.50 Cr | — |
| Taxes Refund Paid | -1.91 Cr | -1.32 Cr | -2.28 Cr | -3.59 Cr | — |
| Change In Working Capital | -0.50 Cr | -12.42 Cr | -9.45 Cr | -9.93 Cr | — |
| Change In Other Current Liabilities | 5.07 Cr | -1.99 Cr | 23.69 Cr | -3.61 Cr | — |
| Change In Other Current Assets | 39.54 Cr | -4.04 Cr | 26.77 Cr | -37.90 Cr | — |
| Change In Payable | -74.72 Cr | 1.15 Cr | 16.85 Cr | 0.26 Cr | — |
| Change In Inventory | -10.80 Cr | -5.86 Cr | -15.14 Cr | 4.78 Cr | — |
| Change In Receivables | 40.43 Cr | -1.20 Cr | -62.49 Cr | 25.73 Cr | — |
| Other Non Cash Items | 4.02 Cr | 4.38 Cr | 2.87 Cr | 2.00 Cr | — |
| Deferred Tax | 0.00 | -0.67 Cr | — | — | — |
| Depreciation And Amortization | 1.94 Cr | 1.70 Cr | 1.57 Cr | 1.99 Cr | — |
| Depreciation | 1.94 Cr | 1.70 Cr | 1.57 Cr | 1.99 Cr | — |
| Net Income From Continuing Operations | 6.10 Cr | 5.34 Cr | 6.01 Cr | 10.03 Cr | — |
| Issuance Of Debt | — | 0.07 Cr | 4.22 Cr | 0.00 | — |
| Long Term Debt Issuance | — | 0.07 Cr | 4.22 Cr | 0.00 | — |
| Net Other Investing Changes | — | — | — | 1.38 Cr | — |
| Stock Based Compensation | — | — | — | 0.00 | 0.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Aarey Drugs & Pharmaceuticals Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.